MAYFAIR DEVELOPMENTS S.A.S
Madame Natacha CHETRITT-BONNEYRAT

18 rue Sénac de Meilhan

17000 La Rochelle - France

+33 (0)5 46 28 74 41

YouTube.png
linkedin-logo.png

ØREBLUE®

 HEARING INNOVATION

 

HYPERACUSIS AND TINNITUS

 

Personnalized

hearing therapy

 

 

 

 

 

The ØREBLUE® method is a personalized sound-based hearing therapy designed

to restore cortical organization.

Its aim is to reduce hyperactive nervous system responses (in the autonomic and limbic systems)

in the case of tinnitus, and to increase the dynamic range of sound by increasing the plasticity

of subconscious neural networks stimulated in the case of hyperacusis.

 

It has been observed that the symptoms of tinnitus and hyperacusis provoke generalized

states of hypervigilance in subjects, which lead to an aversive reflex, similar to the reflex that is triggered

by any threat to well-being.

 

In such cases, the brain may attempt to filter or remove the subject from the stimulus identified as intrusive.

 

This is why, unlike therapies that use noise generators, the ØREBLUE® method uses music.

One of the major advantages of this choice is to place the patient in a highly receptive state,

which increases the acceptability of the treatment.

 

This audible tool is modified using a software program whose specially-developed algorithms

apply acoustic filters tailored to the patient’s medical and emotional hearing pattern,

which means that each therapeutic program is both precise and fully personalized.

 

The ØREBLUE® method was developed thanks to the large volume of medical and acoustic

data analyzed, and thanks to the development by a French engineering firm of an innovative

digital device to process sound signals.

 

The ØREBLUE® method now makes it possible to permanently eliminate the symptoms

of hyperacusis and to significantly reduce, or even eliminate, the symptoms of tinnitus,

rather than artificially blocking them out.

Certified Medical Devices

Enregistred A.N.S.M

Agence Nationale de Sécurité du Médicament et des Produits de Santé

The device developed for the ØREBLUE® method is certified as officially meeting the highest safety and performance standards required for healthcare equipment, and guarantees that the risk-benefit ratio has been clearly demonstrated in treatments of hyperacusis and tinnitus, in accordance with EU Directive 93/42/EEC on medical devices.

BSI Logo CMYK (002).png

MD667380

MD667380

CE667381

Directive 93/42/EEC Médical Devices 

VIDÉO YOUTUBE

Natacha

Chetritt-Bonneyrat

 

French winner of the 2019 Audiologist Of The Year Competition.

Founder of the ØREBLUE® therapeutic protocol for the

treatment of tinnitus and hyperacisis.

 

Audiologist at La Rochelle in France

Hearing Institute Of Resources

RECONNECT

TO THE LIFE

WITH  ØREBLUE® METHOD

 

CLINICAL TECHNOLOGY

Certified Médical Devices Class IIa - European Directive 93/42/EEC

Our ambition today, to be with you tomorrow

Contact us

 
This site was designed with the
.com
website builder. Create your website today.
Start Now